🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

serotype 2 - Medicines in Ireland

8 authorised products containing serotype 2, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 8 authorised medicines
MedicineActive substanceLicence holderStatus
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
EU/1/22/1699/001
 Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) Takeda GmbH —
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
EU/1/22/1699/002
 Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) Takeda GmbH —
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
EU/1/22/1699/003
 Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) Takeda GmbH —
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
EU/1/22/1699/004
 Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) Takeda GmbH —
Qdenga powder and solvent for solution for injection
EU/1/22/1699/001
 Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated Takeda Pharmaceuticals International AG Ireland Branch —
Qdenga powder and solvent for solution for injection
EU/1/22/1699/002
 Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated Takeda Pharmaceuticals International AG Ireland Branch —
Qdenga powder and solvent for solution for injection
EU/1/22/1699/003
 Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated Takeda Pharmaceuticals International AG Ireland Branch —
Qdenga powder and solvent for solution for injection
EU/1/22/1699/004
 Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated Takeda Pharmaceuticals International AG Ireland Branch —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.